Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis

References

• Asadullah K, Sterry W, Volk HD. (2003). Interleukin-10 therapy—Review of a new approach. Pharmacol Rev, 55, 241–69
   PubMed Web of Science ®Google Scholar
• Bai A, Lu N, Guo Y, et al. (2009). All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol, 86, 959–69
   PubMed Web of Science ®Google Scholar
• Chen GQ, Chen YY, Wang XS, et al. (2010). Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats. Brain Res, 1309, 116–25
   PubMed Web of Science ®Google Scholar
• Chow SC. (2009). Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases. Arch Immunol Ther Exp (Warsz), 57, 243–51
   PubMed Web of Science ®Google Scholar
• Conway D, Cohen JA. (2010). Combination therapy in multiple sclerosis. Lancet Neurol, 9, 299–308
   PubMed Web of Science ®Google Scholar
• Dong C. (2009). Mouse Th17 cells: Current understanding of their generation and regulation. Eur J Immunol, 39, 640–4
   Google Scholar
• El-Behi M, Rostami A, Ciric B. (2010). Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol, 5, 189–97
   PubMed Web of Science ®Google Scholar
• Elias KM, Laurence A, Davidson TS, et al. (2008). Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood, 111, 1013–20
   PubMed Web of Science ®Google Scholar
• Eller P, Eller K, Wolf AM, et al. (2010). Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis. Kidney Int, 77, 428–35
   PubMedGoogle Scholar
• Fletcher JM, Lalor SJ, Sweeney CM, et al. (2010). T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol, 162, 1–11
   PubMed Web of Science ®Google Scholar
• Hofstetter H, Gold R, Hartung HP. (2009). Th17 Cells in MS and Experimental Autoimmune Encephalomyelitis. Int MS J, 16, 12–8
   PubMedGoogle Scholar
• Jadidi-Niaragh F, Mirshafiey A. (2011). Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol, 74, 1–13
   PubMed Web of Science ®Google Scholar
• Jager A, Dardalhon V, Sobel RA, et al. (2009). Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol, 183, 7169–77
   PubMed Web of Science ®Google Scholar
• Kagami S, Owada T, Kanari H, et al. (2009). Protein geranylgeranylation regulates the balance between Th17 cells and Foxp3+ regulatory T cells. Int Immunol, 21, 679–89
   PubMed Web of Science ®Google Scholar
• Kinoshita K, Yoo BS, Nozaki Y, et al. (2003). Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice. J Immunol, 170, 5793–8
   PubMed Web of Science ®Google Scholar
• Klemann C, Raveney BJ, Oki S, Yamamura T. (2009). Retinoid signals and Th17-mediated pathology. Nihon Rinsho Meneki Gakkai Kaishi, 32, 20–8
   Google Scholar
• Korn T, Oukka M, Kuchroo V, Bettelli E. (2007a). Th17 cells: effector T cells with inflammatory properties. Semin Immunol, 19, 362–71
   PubMed Web of Science ®Google Scholar
• Korn T, Reddy J, Gao W, et al. (2007b). Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med, 13, 423–31
   PubMed Web of Science ®Google Scholar
• Lees JR, Iwakura Y, Russell JH. (2008). Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines. J Immunol, 180, 8066–72
   Google Scholar
• Lovett-Racke AE, Racke MK. (2002). Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cells. Cell Immunol, 215, 54–60
   PubMed Web of Science ®Google Scholar
• Mao P, Reddy PH. (2010). Is multiple sclerosis a mitochondrial disease? Biochim Biophys Acta, 1802, 66–79
   PubMed Web of Science ®Google Scholar
• Massacesi L, Abbamondi AL, Giorgi C, et al. (1987). Suppression of experimental allergic encephalomyelitis by retinoic acid. J Neurol Sci, 80, 55–64
   Google Scholar
• Milo R, Panitch H. (2011). Combination therapy in multiple sclerosis. J Neuroimmunol, 231, 23–31
   PubMed Web of Science ®Google Scholar
• Mosayebi G, Ghazavi A, Ghasami K, et al. (2011). Therapeutic effect of vitamin D3 in multiple sclerosis patients. Immunol Invest, 40, 627–39
   PubMed Web of Science ®Google Scholar
• Mosayebi G, Ghazavi A, Salehi H, et al. (2007). Effect of sesame oil on the inhibition of experimental autoimmune encephalomyelitis in C57BL/6 mice. Pak J Biol Sci, 10, 1790–6
   PubMedGoogle Scholar
• Mucida D, Park Y, Kim G, et al. (2007). Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science, 317, 256–60
   PubMed Web of Science ®Google Scholar
• Neuhaus O, Stuve O, Archelos JJ, Hartung HP. (2005). Putative mechanisms of action of statins in multiple sclerosis–comparison to interferon-beta and glatiramer acetate. J Neurol Sci, 233, 173–7
   PubMedGoogle Scholar
• Nozaki Y, Yamagata T, Sugiyama M, et al. (2006). Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. Clin Immunol, 119, 272–9
   PubMed Web of Science ®Google Scholar
• Osanai M, Nishikiori N, Murata M, et al. (2007). Cellular retinoic acid bioavailability determines epithelial integrity: Role of retinoic acid receptor alpha agonists in colitis. Mol Pharmacol, 71, 250–8
   PubMed Web of Science ®Google Scholar
• Oukka M. (2007). Interplay between pathogenic Th17 and regulatory T cells. Ann Rheum Dis, 66 Suppl 3, iii87–90
   Google Scholar
• Racke MK, Burnett D, Pak SH, et al. (1995). Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol, 154, 450–8
   PubMed Web of Science ®Google Scholar
• Saraiva M, O'Garra A. (2010). The regulation of IL-10 production by immune cells. Nat Rev Immunol, 10, 170–81
   PubMed Web of Science ®Google Scholar
• Soos JM, Stuve O, Youssef S, et al. (2002). Cutting edge: oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate. J Immunol, 169, 2231–5
   Google Scholar
• Steinman L, Zamvil SS. (2006). How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol, 60, 12–21
   PubMed Web of Science ®Google Scholar
• Tafreshi AP, Ahmadi A, Ghaffarpur M, et al. (2008). An Iranian herbal-marine medicine, MS14, ameliorates experimental allergic encephalomyelitis. Phytother Res, 22, 1083–6
   PubMed Web of Science ®Google Scholar
• Van YH, Lee WH, Ortiz S, et al. (2009). All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells. Diabetes, 58, 146–55
   PubMed Web of Science ®Google Scholar
• van der Most PJ, Dolga AM, Nijholt IM, et al. (2009). Statins: mechanisms of neuroprotection. Prog Neurobiol, 88, 64–75
   PubMed Web of Science ®Google Scholar
• Vollmer T, Key L, Durkalski V, et al. (2004). Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet, 363, 1607–8
   PubMed Web of Science ®Google Scholar
• Vosoughi R, Freedman MS. (2010). Therapy of MS. Clin Neurol Neurosurg, 112, 365–85
   PubMed Web of Science ®Google Scholar
• Youssef S, Stuve O, Patarroyo JC, et al. (2002). The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature, 420, 78–84
   PubMed Web of Science ®Google Scholar
• Zhang X, Markovic-Plese S. (2008). Statins' immunomodulatory potential against Th17 cell-mediated autoimmune response. Immunol Res, 41, 165–74
   PubMedGoogle Scholar
• Zunino SJ, Storms DH, Stephensen CB. (2007). Diets rich in polyphenols and vitamin A inhibit the development of type I autoimmune diabetes in nonobese diabetic mice. J Nutr, 137, 1216–21
   PubMed Web of Science ®Google Scholar